2010-09-17 |
2010-09-17 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
60 000
+150.0%
1,08
64 800 USD
|
60 000
+150.0%
|
1,08
|
64 800 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
5 000
+14.3%
1,07
5 350 USD
|
5 000
+14.3%
|
1,07
|
5 350 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
500
+1.4%
1,08
538 USD
|
500
+1.4%
|
1,08
|
538 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
2 500
+7.8%
1,08
2 700 USD
|
2 500
+7.8%
|
1,08
|
2 700 USD
|
|
2010-09-17 |
2010-09-15 |
A
Achat
|
Garone Michael
Secretary, CFO
Dirigeant
|
32 000
+inf%
1,10
35 200 USD
|
32 000
+inf%
|
1,10
|
35 200 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
7 000
-25.5%
0,70
4 900 USD
|
7 000
-25.5%
|
0,70
|
4 900 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-15.4%
0,70
3 500 USD
|
5 000
-15.4%
|
0,70
|
3 500 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-13.3%
0,71
3 525 USD
|
5 000
-13.3%
|
0,71
|
3 525 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
5 000
-11.8%
0,72
3 600 USD
|
5 000
-11.8%
|
0,72
|
3 600 USD
|
|
2009-12-10 |
2009-12-09 |
V
Vente
|
Riley Gary
VP, Nonclinical Dev & Appl Bio
Dirigeant
|
7 500
-15.0%
0,74
5 550 USD
|
7 500
-15.0%
|
0,74
|
5 550 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
14 744
+41.8%
4,20
61 925 USD
|
14 744
+41.8%
|
4,20
|
61 925 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
200
+0.6%
4,19
838 USD
|
200
+0.6%
|
4,19
|
838 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.3%
4,19
419 USD
|
100
+0.3%
|
4,19
|
419 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.3%
4,18
418 USD
|
100
+0.3%
|
4,18
|
418 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
737
+2.2%
4,17
3 073 USD
|
737
+2.2%
|
4,17
|
3 073 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
500
+1.5%
4,16
2 080 USD
|
500
+1.5%
|
4,16
|
2 080 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
6 000
+21.7%
4,15
24 900 USD
|
6 000
+21.7%
|
4,15
|
24 900 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
4 400
+18.9%
4,14
18 216 USD
|
4 400
+18.9%
|
4,14
|
18 216 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
300
+1.3%
4,13
1 239 USD
|
300
+1.3%
|
4,13
|
1 239 USD
|
|
2008-08-20 |
2008-08-19 |
A
Achat
|
Riley Gary
VP, Nonclinical Development
Dirigeant
|
100
+0.4%
4,11
411 USD
|
100
+0.4%
|
4,11
|
411 USD
|
|